BlackRock Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

BlackRock Group’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$111K	Buy	23,019 +1,386	+6%	+$41.1K	﹤0.01%	2813
2016 Q3	$997K	Buy	21,633 +273	+1%	+$15.4K	﹤0.01%	2039
2016 Q2	$1.09M	Buy	21,360 +1,673	+8%	+$83.1K	﹤0.01%	1927
2016 Q1	$833K	Buy	19,687 +6,858	+53%	+$349K	﹤0.01%	2025
2015 Q4	$1.01M	Buy	12,829 +5,957	+87%	+$344K	﹤0.01%	1894
2015 Q3	$278K	Sell	6,872 -12,320	-64%	-$653K	﹤0.01%	2421
2015 Q2	$1M	Buy	19,192 +16,434	+596%	+$818K	﹤0.01%	1962
2015 Q1	$128K	Buy	2,758 +291	+12%	+$15.1K	﹤0.01%	2605
2014 Q4	$110K	Buy	2,467 +1,229	+99%	+$51.6K	﹤0.01%	2649
2014 Q3	$48K	Buy	1,238 +381	+44%	+$15K	﹤0.01%	2691
2014 Q2	$36K	Buy	857 +495	+137%	+$18.2K	﹤0.01%	2732
2014 Q1	$13K	Sell	362 -59,332	-99%	-$2M	﹤0.01%	2703
2013 Q4	$1.93M	Buy	+59,694	New	+$1.77M	﹤0.01%	1544

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock Group's ISEE Position: Q4 2016 in Review

BlackRock Group increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 6.4% in Q4 2016, buying an estimated $41.1K and bringing the position to 23,019 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2813.

BlackRock Group first reported a position in ISEE in Q4 2013 and has held it in 13 quarters since. The position peaked at $1.93M in Q4 2013. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

BlackRock Group held 23,019 shares of IVERIC bio, Inc. Common Stock worth $111K as of Q4 2016.
BlackRock Group bought 1,386 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $41.1K.
IVERIC bio, Inc. Common Stock made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2813 holding.
BlackRock Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and has held it in 13 quarters since.
BlackRock Group's IVERIC bio, Inc. Common Stock position peaked at $1.93M in Q4 2013.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.